Paloma Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-69,900
Closed -$6.94M 2694
2019
Q3
$6.94M Sell
69,900
-17,129
-20% -$1.63M 0.14% 115
2019
Q2
$8.04M Buy
87,029
+21,799
+33% +$2.07M 0.14% 129
2019
Q1
$6.15M Buy
65,230
+47,762
+273% +$4.18M 0.15% 123
2018
Q4
$1.12M Sell
17,468
-129,397
-88% -$9.55M 0.03% 420
2018
Q3
$13.1M Buy
146,865
+76,617
+109% +$6.77M 0.24% 56
2018
Q2
$5.58M Buy
70,248
+52,954
+306% +$4.4M 0.1% 153
2018
Q1
$1.54M Sell
17,294
-4,210
-20% -$404K 0.02% 728
2017
Q4
$2.24M Buy
+21,504
New +$2.43M 0.03% 621
2017
Q3
Sell
-1,885
Closed -$257K 2719
2017
Q2
$245K Sell
1,885
-11,033
-85% -$1.35M ﹤0.01% 1898
2017
Q1
$1.61M Sell
12,918
-18,427
-59% -$2.21M 0.02% 929
2016
Q4
$3.63M Buy
31,345
+6,540
+26% +$728K 0.04% 378
2016
Q3
$2.59M Sell
24,805
-80,930
-77% -$8.76M 0.03% 424
2016
Q2
$10.4M Sell
105,735
-41,617
-28% -$4.3M 0.11% 99
2016
Q1
$14.7M Buy
147,352
+143,910
+4,181% +$14.8M 0.24% 56
2015
Q4
$412K Sell
3,442
-38,255
-92% -$4.43M 0.01% 1154
2015
Q3
$4.51M Buy
41,697
+20,121
+93% +$2.5M 0.1% 127
2015
Q2
$2.5M Buy
21,576
+15,765
+271% +$1.8M 0.05% 366
2015
Q1
$669K Sell
5,811
-889
-13% -$106K 0.02% 658
2014
Q4
$749K Buy
+6,700
New +$707K 0.03% 520
2014
Q3
Sell
-49,044
Closed -$4.21M 1596
2014
Q2
$4.21M Buy
49,044
+32,244
+192% +$2.45M 0.17% 133
2014
Q1
$1.17M Buy
16,800
+10,910
+185% +$864K 0.08% 220
2013
Q4
$497K Sell
5,890
-48,740
-89% -$3.86M 0.02% 589
2013
Q3
$4.2M Buy
54,630
+51,126
+1,459% +$3.58M 0.17% 100
2013
Q2
$205K Buy
+3,504
New +$211K 0.01% 921

Other funds holding CELG

Paloma Partners's CELG Position: Q4 2019 in Review

Paloma Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 69,900 shares — an estimated $6.94M sold.

Paloma Partners first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $14.7M in Q1 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Paloma Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Paloma Partners sold 69,900 Celgene Corp shares in Q4 2019, an estimated $6.94M.
  • Paloma Partners first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • Paloma Partners's Celgene Corp position peaked at $14.7M in Q1 2016.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Paloma Partners's 13F filing for Q4 2019, filed 14 Feb 2020.